Biotech Startups
10,099 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Starton Therapeutics is a clinical-stage biotechnology company that reformulates FDA-approved drugs using proprietary controlled delivery systems to improve their pharmacokinetic profiles. It develops subcutaneous, oral, and transdermal delivery methods aimed at achieving better outcomes in existing or new indications.
0 investors
0 investors
0 investors
0 investors
Stem Cell Reserve (SCR) operates a hybrid private and public umbilical cord blood and cord tissue biobank, using proprietary methods to store cord products and manufacture cord-derived stem cell and biomatrix products for regenerative medicine. The company serves expectant parents (private banking) and donors (public banking), initially focusing on the Houston Metropolitan Area with plans to expand across major U.S. cities.
0 investors
0 investors
0 investors
Stemina Biomarker Discovery develops in vitro assays using human stem cell-derived cells to predict drug toxicity and support drug discovery and development. The company serves pharmaceutical and biotech firms seeking developmental and cardiac safety screening.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Stork Therapeutics is developing CAR T cell therapies to expand the potential of that treatment modality.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Sulfagenix develops SG1002, an oral hydrogen sulfide prodrug designed to treat oxidative stress-related diseases including cardiovascular disorders, cancer, and other chronic conditions. The company targets patients with conditions ranging from heart failure to cancer, diabetes, and neurodegeneration.
0 investors
SummaCor develops medical device technologies, including the LCAPP, for cardiac care led by a team of cardiologists and engineers. The company focuses on heart-related medical technology with clinical and advisory input from cardiology and heart failure specialists.
0 investors